Son Dakika

Tropical Storm Arthur Brings Heavy Rains to Gulf Coast Labor Department Warns States on Unemployment Fraud, Threatens Funding Withholding FTC Lawsuit Highlights Challenges in Policing App Store Scams AI Agents Train Robots Autonomously Using ENPIRE Harness Social Media Platforms Empower Users with Algorithm Customization Tools Slate Auto's Blank Slate EV Truck Pricing Leaked, Starting at $24,950 Anthropic Joins Frontier Carbon Removal Collective with $915 Million Pledge Federal Reserve Holds Interest Rates Steady, Signals Potential Increase Amid Inflation Concerns Trump Administration Orders Anthropic to Block Foreign Nationals from AI Models G7 Leaders Voice Concerns Over US Control of AI Models Tropical Storm Arthur Brings Heavy Rains to Gulf Coast Labor Department Warns States on Unemployment Fraud, Threatens Funding Withholding FTC Lawsuit Highlights Challenges in Policing App Store Scams AI Agents Train Robots Autonomously Using ENPIRE Harness Social Media Platforms Empower Users with Algorithm Customization Tools Slate Auto's Blank Slate EV Truck Pricing Leaked, Starting at $24,950 Anthropic Joins Frontier Carbon Removal Collective with $915 Million Pledge Federal Reserve Holds Interest Rates Steady, Signals Potential Increase Amid Inflation Concerns Trump Administration Orders Anthropic to Block Foreign Nationals from AI Models G7 Leaders Voice Concerns Over US Control of AI Models

FRONTEO

Sabit2 haber1 kaynakSon güncelleme: 03.06.2026

İlgili EtiketlerAI KIBIT drug discovery target molecules AlphaFold Preferred Networks pancreatic cancer Astellas Pharma

Son Haberler

FRONTEO's AI Aims to Accelerate Drug Discovery by Identifying Novel Target Molecules

Teknoloji·03.06.2026AI özeti

FRONTEO's AI Aims to Accelerate Drug Discovery by Identifying Novel Target Molecules

FRONTEO is focusing on identifying target molecules for drug discovery using its AI engine "KIBIT," which analyzes論文 data to find unknown candidates. This accelerates a process that previously took years to mere days, addressing a key bottleneck in AI-driven drug development.

FRONTEO AI創薬支援サービス「DDAIF」を強化、新ラボ開設で標的分子探索・仮説構築能力を向上

18.05.2026AI özeti

FRONTEO AI創薬支援サービス「DDAIF」を強化、新ラボ開設で標的分子探索・仮説構築能力を向上

FRONTEOはAI創薬支援サービス「DDAIF」を強化するため、新ラボ「KIBIT AI Biology Lab」を開設。AIエンジン「KIBIT」を活用し、標的分子探索・仮説構築能力を向上させ、バイオベンチャーや製薬企業に情報提供する。